1. Home
  2. FOLD vs PAYO Comparison

FOLD vs PAYO Comparison

Compare FOLD & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$5.68

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
PAYO
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
PAYO
Price
$9.92
$5.68
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$30.29
$9.79
AVG Volume (30 Days)
4.6M
2.8M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
$598,704,000.00
$1,039,820,000.00
Revenue This Year
$21.12
$11.18
Revenue Next Year
$21.23
$7.45
P/E Ratio
N/A
$31.18
Revenue Growth
21.28
10.58
52 Week Low
$5.51
$4.92
52 Week High
$10.57
$11.19

Technical Indicators

Market Signals
Indicator
FOLD
PAYO
Relative Strength Index (RSI) 64.67 49.24
Support Level $9.56 $5.65
Resistance Level $10.05 $5.87
Average True Range (ATR) 0.37 0.17
MACD -0.02 0.04
Stochastic Oscillator 51.14 65.74

Price Performance

Historical Comparison
FOLD
PAYO

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

Share on Social Networks: